168
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study

ORCID Icon, , , , ORCID Icon, & show all
Pages 735-740 | Published online: 10 Aug 2020

References

  • Morgan IGO-MK, Saw SM. Myopia. Lancet. 2012;379(9827):1739–1748. doi:10.1016/S0140-6736(12)60272-4
  • Wong YLSS. Epidemiology of pathologic myopia in Asia and worldwide. Asia Pac J Ophthalmol. 2016;5(6):394–402. doi:10.1097/APO.0000000000000234
  • Morgan IGHM, Rose KA. Epidemic of pathologic myopia: what can laboratory studies and epidemiology tell us? Retina. 2017;37(5):989–997. doi:10.1097/IAE.0000000000001272
  • He MZJ, Liu Y, Xu J, Pokharel GP, Ellwein LB. Refractive error and visual impairment in urban children in southern China. Invest Ophthalmol Vis Sci. 2004;45:793–799. doi:10.1167/iovs.03-1051
  • Sun J, Zhou J, Zhao P, et al. High prevalence of myopia and high myopia in 5060 Chinese University Students in Shanghai. Invest Ophthalmol Vis Sci. 2012;53(12):7504–7509. doi:10.1167/iovs.11-8343
  • Holden BAFT, Wilson DA, Jong M, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–1042. doi:10.1016/j.ophtha.2016.01.006
  • Matsuda KPK. Recent trend of increasing myopia can be traced to infancy. Med Hypotheses. 2019;128:78–82. doi:10.1016/j.mehy.2019.05.017
  • Huang JWD, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in children a network meta-analysis. Ophthalmology. 2016;123(4):697–708. doi:10.1016/j.ophtha.2015.11.010
  • The Impact of Myopia and High Myopia. Report of the joint world health organization–brien holden vision institute global scientific meeting on myopia, University of New South Wales, Sydney, Australia. 16–18 March 2015. Geneva: World Health Organization;2017. Licence: CC BY-NC-SA 3.0 IGO
  • Zhao F, Ma JX. Will the long-term use of atropine eye drops in children increase the risk of dry eye? Med Hypotheses. 2019;132:109331. doi:10.1016/j.mehy.2019.109331
  • Shih KCCT, Ng AL, et al. Use of atropine for prevention of childhood myopia progression in clinical practice. Eye Contact Lens. 2016;42(1):16–23. doi:10.1097/ICL.0000000000000189
  • Chia ALQ, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391–399. doi:10.1016/j.ophtha.2015.07.004
  • Chia ACW, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses. Ophthalmology. 2012;119(2):347–354. doi:10.1016/j.ophtha.2011.07.031
  • Chia ACW, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157(2):451–457.e451. doi:10.1016/j.ajo.2013.09.020
  • Burgalassi SPL, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999;31(3):229–235. doi:10.1159/000055537
  • Chen L, Pi L, Fang J, Chen X, Ke N, Liu Q. High incidence of dry eye in young children with allergic conjunctivitis in Southwest China. Acta Ophthalmol. 2016;94:e727e730. doi:10.1111/aos.13093
  • Arita KI R, Maeda S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009;116(11):2058e2051–2063e2051. doi:10.1016/j.ophtha.2009.04.037
  • Bartuzel MMS-ID, Iskander DR. Automatic dynamic tear meniscus measurement in optical coherence tomography. Biomed Opt Express. 2014;5:2759–2768. doi:10.1364/BOE.5.002759
  • Schiffman RM, Jacobsen MDC,G, Hirsch JD, Reis, BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615
  • Gunay M. GC, E. Yildiz et al. Ocular surface characteristics in diabetic children. Curr Eye Res. 2016;41(12):1526–1531. doi:10.3109/02713683.2015.1136421
  • Vasudevan B, Ciuffreda KJ, Ludlam DP. Accommodative training to reduce nearwork-induced transient myopia. Optom Vis Sci. 2009;86:1287–1294. doi:10.1097/OPX.0b013e3181bb44cf
  • Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) study. Ophthalmology. 2019;126(1):113–124. doi:10.1016/j.ophtha.2018.05.029
  • Guo L, Fan L, Tao J, et al. Use of topical 0.01% atropine for controlling near work-induced transient myopia: a randomized, double-masked, placebo-controlled study. J Ocul Pharmacol Ther. 2020;36(2):97–101. doi:10.1089/jop.2019.0062
  • Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584–589. doi:10.1097/00003226-199811000-00002
  • Schoenwald RD, Vidvauns S, Wurster DE, Barfknecht CF. The influence of tear proteins on the film stability of rabbit tear extracts. J Ocul Pharmacol Ther. 1998;14:15–29. doi:10.1089/jop.1998.14.15
  • Bucolo C, Musumeci M, Salomone S, et al. Effects of topical fucosyl-lactose, a milk oligosaccharide, on dry eye model: an example of nutraceutical candidate. Front Pharmacol. 2015;6:280. doi:10.3389/fphar.2015.00280